Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Broggini

Showing results (21-30 of 177) with videos related to

Pageof 18
Sort By:
International Journal of Cancer|May 4, 1995
Decreased cytotoxic effects of doxorubicin in a human ovarian cancer-cell line expressing wild-type p53 and WAF1/CIP1 genesF Vikhanskaya, M D'Incalci, M Broggini
Current Medicinal Chemistry. Anti-Cancer Agents|May 12, 2004
New molecules and strategies in the field of anticancer agentsS Marchini, M D'Incalci, M Broggini
Current Medicinal Chemistry|January 20, 2012
RAS/RAF/MEK inhibitors in oncologyP Rusconi, E Caiola, M Broggini
European Journal of Cancer & Clinical Oncology|March 1, 1983
Subcellular distribution of adriamycin in the liver and tumor of 3LL-bearing miceM Broggini, P Ghersa, M G Donelli
The Lancet. Oncology|July 8, 2015
Correction to Lancet Oncol 2015; 16: 747. EGFR mutations and EGFR tyrosine kinase inhibitorsV Torri, M Broggini, M C Garassino
Nucleic Acids Research|October 25, 1991
O6-methylguanine inhibits the binding of transcription factors to DNAM Bonfanti, M Broggini, C Prontera, et al.
Recenti Progressi in Medicina|September 1, 1986
[New etiopathologic and therapeutic perspectives in ureteral colic. Evaluation of clinical experience with diclofenac sodium and indomethacin]E Grossi, U Garagiola, A Marconi, et al.
Experimental Cell Research|September 15, 1996
Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53F Vikhanskaya, E Erba, M D'Incalci, et al.
Lancet (London, England)|January 1, 1983
Transplacental passage of doxorubicinM d'Incalci, M Broggini, M Buscaglia, et al.
British Medical Journal (Clinical Research Ed.)|April 7, 1984
Diclofenac sodium in biliary colic: a double blind trialM Broggini, E Corbetta, E Grossi, et al.
Pageof 18

Showing results (21-30 of 177) with videos related to

Sort By:
Pageof 18
International Journal of Cancer|May 4, 1995
Decreased cytotoxic effects of doxorubicin in a human ovarian cancer-cell line expressing wild-type p53 and WAF1/CIP1 genesF Vikhanskaya, M D'Incalci, M Broggini
Current Medicinal Chemistry. Anti-Cancer Agents|May 12, 2004
New molecules and strategies in the field of anticancer agentsS Marchini, M D'Incalci, M Broggini
Current Medicinal Chemistry|January 20, 2012
RAS/RAF/MEK inhibitors in oncologyP Rusconi, E Caiola, M Broggini
European Journal of Cancer & Clinical Oncology|March 1, 1983
Subcellular distribution of adriamycin in the liver and tumor of 3LL-bearing miceM Broggini, P Ghersa, M G Donelli
The Lancet. Oncology|July 8, 2015
Correction to Lancet Oncol 2015; 16: 747. EGFR mutations and EGFR tyrosine kinase inhibitorsV Torri, M Broggini, M C Garassino
Nucleic Acids Research|October 25, 1991
O6-methylguanine inhibits the binding of transcription factors to DNAM Bonfanti, M Broggini, C Prontera, et al.
Recenti Progressi in Medicina|September 1, 1986
[New etiopathologic and therapeutic perspectives in ureteral colic. Evaluation of clinical experience with diclofenac sodium and indomethacin]E Grossi, U Garagiola, A Marconi, et al.
Experimental Cell Research|September 15, 1996
Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53F Vikhanskaya, E Erba, M D'Incalci, et al.
Lancet (London, England)|January 1, 1983
Transplacental passage of doxorubicinM d'Incalci, M Broggini, M Buscaglia, et al.
British Medical Journal (Clinical Research Ed.)|April 7, 1984
Diclofenac sodium in biliary colic: a double blind trialM Broggini, E Corbetta, E Grossi, et al.
Pageof 18